IRCT20240415061495N1RecruitingPhase 3
Investigating the effect of Methylphenidate (Ritalin) on the level of consciousness of patients with traumatic brain injury in Imam Khomeini Hospital of Urmia
Oroumia University of Medical Sciences0 sites962 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 3
- Status
- Recruiting
- Sponsor
- Enrollment
- 962
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 15 years to 60 years (—)
- Sex
- All
Inclusion Criteria
- •Patients with traumatic brain injury were between 15 and 60 years old
- •GCS between 7 and 11
- •No history of brain damage, seizures, high blood pressure, ischemic heart disease and diabetes
- •No addiction to psychedelics and narcotics or Amphetamine use
- •Heart rate less than 120 beats per minute
Exclusion Criteria
- •Evidence of drug allergy
- •Patients who could not tolerate enteral feeding despite maximal medical treatment in the first 48 hours of admission
Investigators
Similar Trials
Not yet recruiting
Phase 4
Methylphenidate in Adults with Severe Traumatic brain injury for the Enhancement of Recovery (MASTER)Traumatic brain injuryPhysical Medicine / Rehabilitation - Other physical medicine / rehabilitationInjuries and Accidents - Other injuries and accidentsACTRN12615001044516Royal Rehab20
Recruiting
Phase 3
Investigating the effect of methylphenidate on the level of consciousness in loss of consciousness patients due to poisoningIRCT20220305054196N4Shahid Beheshti University of Medical Sciences64
Recruiting
Phase 2
The effects of methylphenidate and atomoxetine on emotional intelligence, executive function and self-efficacy of 12-18-year-old adolescents with ADHDIRCT20160523028008N31Hamedan University of Medical Sciences76
Active, not recruiting
Not Applicable
The effect of methylphenidate (Ritalin ®) on the severity of stuttering.stutteringEUCTR2013-004206-26-BEVakgroep Huisartsgeneeskunde VUB
Completed
Phase 2
Investigating the effectiveness of methylphenidate and combination of magnesium and zinc and calcium in treatment of patients with attention deficit hyperactivity disorder (ADHD) in Zahedan CityIRCT2015092624209N1Vice Chancellor for Research and Technology at Zahedan University of Medical Sciences and Health Ser40